Updated knowledge, partitioning and ecological risk of pharmaceuticals and personal care products in global aquatic environments.
Marisa de Jesus Silva ChavesJonatas KulzerPaula da Rosa Pujol de LimaSergiane Caldas BarbosaEdnei Gilberto PrimelPublished in: Environmental science. Processes & impacts (2022)
Over the last few decades, the occurrence of pharmaceuticals and personal care products (PPCPs) in aquatic environments has generated increasing public concern. In this review, data on the presence of PPCPs in environmental compartments from the past few years (2014-2022) are summarized by carrying out a critical survey of the partitioning among water, sediment, and aquatic organisms. From the available articles on PPCP occurrence in the environment, in Web of Science and Scopus databases, 185 articles were evaluated. Diclofenac, carbamazepine, caffeine, ibuprofen, ciprofloxacin, and sulfamethoxazole were reported to occur in 85% of the studies in at least one of the mentioned matrices. Risk assessment showed a moderate to high environmental risk for these compounds worldwide. Moreover, bioconcentration factors showed that sulfamethoxazole and trimethoprim can bioaccumulate in aquatic organisms, while ciprofloxacin and triclosan present bioaccumulation potential. Regarding spatial distribution, the Asian and European continents presented most studies on the occurrence and effects of PPCPs on the environment, while Africa and Asia are the most contaminated continents. In addition, the impact of COVID-19 on environmental contamination by PPCPs is discussed.
Keyphrases
- risk assessment
- human health
- heavy metals
- healthcare
- palliative care
- health risk assessment
- pseudomonas aeruginosa
- coronavirus disease
- health risk
- sars cov
- quality improvement
- case control
- public health
- gram negative
- big data
- pain management
- cross sectional
- electronic health record
- mental health
- drinking water
- high intensity
- antibiotic resistance genes
- life cycle
- anaerobic digestion